Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer (Q34147279)

31 July 2017

Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer (English)

1 reference

31 July 2017

P Kelly

1

1 reference

31 July 2017

F Paulin

2

1 reference

31 July 2017

D Lamont

3

1 reference

31 July 2017

L Baker

4

1 reference

31 July 2017

S Clearly

5

1 reference

31 July 2017

D Exon

6

1 reference

31 July 2017

A Thompson

7

1 reference

31 July 2017

language of work or name

English

0 references

publication date

31 January 2012

1 reference

31 July 2017

7

1 reference

British Journal of Cancer

inferred from page(s)

published in

1 reference

31 July 2017

106

1 reference

31 July 2017

5

1 reference

31 July 2017

955-961

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.2012.15

31 July 2017

0 references

cites work

Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18F FDG PET: a systematic review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

Role of systemic inflammatory response in predicting survival in patients with primary operable cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

Inflammation and esophageal carcinogenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

Serum amyloid A: an acute-phase protein involved in tumour pathogenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

Quick calculation for sample size while controlling false discovery rate with application to microarray analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

Cancer proteomics and its application to discovery of therapy response markers in human cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

Possible prediction of chemoradiosensitivity of esophageal cancer by serum protein profiling.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy--systematic review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

Proteomics: the next revolution in laboratory medicine?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

The clinical application of proteomics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

Identification of tumor-associated plasma biomarkers using proteomic techniques: from mouse to human

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

Oesophageal cancer: a view over overviews

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemoradiotherapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

Modifications of plasma lipids, lipoproteins and apolipoproteins in advanced cancer patients treated with recombinant interleukin-2 and autologous lymphokine-activated killer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

Acute-phase protein synthesis in human hepatoma cells: differential regulation of serum amyloid A (SAA) and haptoglobin by interleukin-1 and interleukin-6.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

Protein and antibody arrays and their medical applications.

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2012.15

Defective mismatch repair in colon cancer: a prognostic or predictive biomarker?

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2012.15

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2012.15

Usefulness of serum protein profiling for prediction of preoperative chemoradiosensitivity of esophageal cancer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

Preoperative chemotherapy for resectable thoracic esophageal cancer

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3305965

Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries

28 October 2018

1 reference

12 December 2020

Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus

1 reference

12 December 2020

Gastro-oesophageal cancer: facts, myths and surgical folk lore

1 reference

12 December 2020

Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations

1 reference

12 December 2020

Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT)

1 reference

12 December 2020

Hospital volume does not influence long-term survival of patients undergoing surgery for oesophageal or gastric cancer

1 reference

12 December 2020

Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer

1 reference

12 December 2020

Systemic inflammation as a confounding factor in cancer biomarker discovery and validation

1 reference

12 December 2020

Glasgow Prognostic Score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2012.15

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference